Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix and Boostrix Co-administration Study
NCT02052596Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Feb 2014; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02052596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052596.